Skip to main content

Xeloda News

Overall Survival Benefit Up for Pyrotinib + Capecitabine in HER2-Positive Breast Cancer

THURSDAY, Nov. 16, 2023 – For patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer, pyrotinib plus capecitabine offers an overall survival benefit,...

Zolbetuximab Plus CAPOX Beneficial for Advanced mG/GEJ Adenocarcinoma

FRIDAY, Sept. 1, 2023 – For patients with human epidermal growth factor receptor 2 (HER2)-negative, locally advanced unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ)...

Findings of IDEA Collaboration Have Influenced Prescribing Patterns

WEDNESDAY, Aug. 9, 2023 – Changes in prescribing patterns for resected stage III colon cancer have been observed since the abstract presentation of the IDEA collaboration in June 2017, according to...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Colorectal Cancer, Breast Cancer, Metastatic, Breast Cancer

Xeloda patient information at Drugs.com